All Type of News
Ubidecarenone ranks 1st in 2005 bulk output
Daewoong Chemical's ubidecarenone ranked 1st in terms of bulk output value in 2005, according to the report by the Korea Pharmaceutical Manufacturers Association.
The output of ubidecarenone, which was locally prod...
Health ministry sets aside 69.7 billion won for health and medical sector
The Ministry of Health and Welfare said that it will spend 69.7 billion won to support the nation's health and medical sector in 2007.
The ministry proposed next year's health and welfare budget bill of 19.3 trilli...
Modified new drugs made great market success.
A modified new drug market shows a rapid growing in Korea, indicating an ideal answer to explore for further business progress for the local drug industry where the piple line products and R&D capability were vulnerab...
KFDA named 4 new regional heads
The KFDA newly appointed 4 regional KFDA heads on June 29 as Mr. Kim Young-chan at Guangju, Lee Joon-geun at Seoul, Lee Gae-yoong at Gyeongin and Park Soo-cheon at Daejon.
Mr. Kim Yong-hyeon, the former Guangju KFD...
Oral anticancer drug Nexavar granted KFDA approval
Bayer Korea announced on June 28 that the Korea Food and Drug Administration (KFDA) has approved the local marketing of Nexavar (sorafenib) tablets for the first-line treatment of patients with advanced renal cell car...
Daewoong to beef up OTC sales
Daewoong Pharm will beef up its OTC sales from this July by strengthening its ties with associated wholesalers, according to marketing sources on June 28.
To that end, the company will additionally increase the num...
Namyang Drug purchases large distribution center
Namyang Drug, a leading hospital-oriented wholesaler, said on June 19 it has purchased a large drug distribution center in a bid to meet fierce competition in the domestic distribution market.
The distribution cent...
504 frequently prescribing or expensive drugs require bio equivalency test.
The KFDA disclosed a draft of bill titled "Ordinance of designating drugs required for the bio equivalency tests (draft)" on June 28 covering that the bio equivalency test for the total 504 drugs including 273 drugs r...
Local pharmaceutical industry to eye on African markets.
The African drug market has come up as a new rising target for the local drug industry to explore a strategy to overcome the already saturated local marketability by shifting their major markets from the South East As...
NGO still calls for reduction of Iressa price
AstraZeneca Korea's statement that a civil group's petition on the reduction of insurance price of Iressa (gefitinib) is groundless is rekindling another refutation statement.
In its statement on June 28, the Healt...
